Mario Petrini Selected Research

VACOP-B protocol

3/2003

Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mario Petrini Research Topics

Disease

28	Multiple Myeloma 08/2021 - 08/2005
14	Lymphoma (Lymphomas) 01/2019 - 03/2003
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 10/2005
12	Neoplasms (Cancer) 02/2017 - 05/2007
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2007
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 09/2007
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2017 - 03/2003
8	Residual Neoplasm 01/2017 - 09/2004
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2015 - 01/2007
6	Infections 01/2022 - 08/2009
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 08/2007
6	Neutropenia 12/2019 - 01/2007
6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2019 - 09/2004
6	Progressive Multifocal Leukoencephalopathy 05/2010 - 05/2007
5	Leukemia 11/2018 - 06/2010
4	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 10/2005
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2013
3	Aspergillosis 06/2018 - 01/2007
3	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 03/2009
2	Lymphopenia (Lymphocytopenia) 01/2022 - 08/2009
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2021 - 07/2012
2	Carcinogenesis 06/2020 - 06/2010
2	COVID-19 01/2020 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 07/2012
2	Paraproteinemias (Monoclonal Gammopathy) 01/2019 - 10/2010
2	Renal Insufficiency (Renal Failure) 01/2018 - 09/2009
2	Melanoma (Melanoma, Malignant) 05/2012 - 11/2011
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 02/2011 - 01/2010
2	Disease Progression 02/2011 - 04/2007
2	Cardiotoxicity 04/2010 - 12/2005
2	Viremia 02/2010 - 06/2008
2	Coma (Comas) 09/2009 - 05/2007
2	Hemorrhagic Cystitis 04/2009 - 05/2007
2	Primary Myelofibrosis (Myelosclerosis) 08/2008 - 04/2003
1	Klebsiella Infections (Klebsiella Infection) 01/2022
1	Splenomegaly 01/2022
1	Septic Shock (Toxic Shock Syndrome) 01/2022
1	Neutropenic Enterocolitis 09/2021
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 09/2020
1	Pneumonia (Pneumonitis) 12/2019

Drug/Important Bio-Agent (IBA)

18	Rituximab (Mabthera)FDA Link 01/2022 - 12/2004
10	Bortezomib (Velcade)FDA Link 02/2021 - 08/2008
10	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 09/2005
8	Dexamethasone (Maxidex)FDA LinkGeneric 08/2021 - 06/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 03/2003
6	CytokinesIBA 01/2020 - 04/2003
5	Monoclonal AntibodiesIBA 11/2018 - 03/2006
4	Biological ProductsIBA 01/2022 - 02/2011
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022 - 02/2012
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 08/2015
3	nilotinib FDA Link 01/2020 - 11/2016
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2008
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2013
3	Therapeutic UsesIBA 05/2012 - 01/2009
3	LithiumIBA 01/2012 - 10/2003
3	Pharmaceutical PreparationsIBA 01/2009 - 05/2007
2	pomalidomideIBA 08/2021 - 01/2016
2	Lenalidomide (CC 5013)FDA Link 02/2021 - 09/2011
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2012
2	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 01/2017
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 09/2020 - 02/2014
2	ofatumumab FDA Link 12/2019 - 10/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2019 - 07/2011
2	Immunoglobulin G (IgG)IBA 01/2019 - 11/2007
2	XenobioticsIBA 11/2018 - 03/2013
2	Protein Isoforms (Isoforms)IBA 12/2017 - 03/2009
2	Immunoglobulin M (IgM)IBA 02/2017 - 01/2015
2	Thalidomide (Thalomid)FDA Link 01/2017 - 01/2013
2	ibritumomab tiuxetan (Zevalin)FDA Link 03/2014 - 11/2008
2	Arsenic Trioxide (Trisenox)FDA Link 09/2012 - 06/2010
2	liposomal doxorubicin (Doxil)FDA Link 09/2011 - 01/2009
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2011 - 01/2010
2	Dexrazoxane (Zinecard)FDA LinkGeneric 04/2010 - 12/2005
2	AnthracyclinesIBA 04/2010 - 12/2005
2	Biomarkers (Surrogate Marker)IBA 02/2010 - 05/2007
2	AntigensIBA 08/2009 - 02/2008
2	DNA (Deoxyribonucleic Acid)IBA 02/2009 - 01/2008
2	Folic Acid (Vitamin M)FDA LinkGeneric 04/2008 - 05/2007
2	Vincristine (Oncovin)FDA LinkGeneric 01/2008 - 06/2007
2	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2007 - 05/2007
2	purineIBA 04/2007 - 12/2004
1	idelalisibIBA 01/2022
1	RG7388IBA 01/2022
1	carfilzomibIBA 02/2021
1	enasidenibIBA 06/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 06/2020
1	Antiviral Agents (Antivirals)IBA 01/2020

Therapy/Procedure

33	Therapeutics 01/2022 - 09/2004
21	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
6	Stem Cell Transplantation 01/2021 - 09/2009
5	Hematopoietic Stem Cell Transplantation 01/2016 - 06/2008
4	Transplantation 01/2019 - 05/2006
3	Immunotherapy 01/2019 - 11/2011
3	Radioimmunotherapy 06/2012 - 09/2008
3	Aftercare (After-Treatment) 08/2009 - 05/2007
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 08/2005
2	Homologous Transplantation 01/2013 - 08/2005
2	Autologous Transplantation 01/2008 - 06/2007
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2007 - 07/2006